✦ LIBER ✦

70 AN ORAL SMALL-MOLECULE MULTITARGETED RECEPTOR TYROSINE KINASE INHIBITOR, SUNITINIB, DEMONSTRATES GROWTH INHIBITION IN BONE METASTASIS OF RENAL CELL CANCER IN VIVO

✍ Scribed by Maita, Shinya; Yuasa, Takeshi; Tsuchiya, Norihiko; Mitobe, Yoko; Narita, Shintaro; Horikawa, Yohei; Fukui, Iwao; Hatake, Kiyohiko; Kimura, Shinya; Maekawa, Taira; Habuchi, Tomonori

Book ID: 123114293
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 183
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.02.118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib (‘Iressa’), an epidermal growt

Gefitinib (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells

✍ Satoru Shintani; Chunnan Li; Mariko Mihara; Koh-ichi Nakashiro; Hiroyuki Hamakaw 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 239 KB

420 IN VIVO CASTRATION-RESISTANT ACCELER

420 IN VIVO CASTRATION-RESISTANT ACCELERATION OF PROSTATE CANCER INHIBITED BY A SMALL MOLECULE INHIBITOR OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR/INSULIN RECEPTOR TYROSINE KINASE

✍ Inoue, Takamitsu; Zakikhani, Mahvash; Mireuta, Matei; Blouin, Marie-José; Pollak 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 134 KB

Ki26894, a novel transforming growth fac

Ki26894, a novel transforming growth factor-β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line

✍ Shogo Ehata; Aki Hanyu; Makoto Fujime; Yoko Katsuno; Erina Fukunaga; Kouichiro G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

Pilot trial of ZD1839 (IressaTM), an ora

Pilot trial of ZD1839 (IressaTM), an oral inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, in combination with carboplatin (C) and paclitaxel (P) in previously untreated advanced non-small cell lung cancer (NSCLC)

✍ Laurie, S.A; Miller, V.A; Johnson, D; Ng, K.K; Heelan, R.T; Pizzo, B.A; Perez, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

53LBA A phase I/IIa study of icotinib hy

53LBA A phase I/IIa study of icotinib hydrochloride (BPI-2009H), an oral epidermal growth factor receptor tyrosine kinases inhibitor, in patients with advanced non-small-cell lung cancer and other solid tumors

✍ Q. Zhao; J. Zhou; J. Shentu; L. Wu; N. Xu; F. Tan; Y. Wang; D. Yang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB